55 related articles for article (PubMed ID: 38693353)
1. RNA methylation patterns, immune characteristics, and autophagy-related mechanisms mediated by N6-methyladenosine (m6A) regulatory factors in venous thromboembolism.
Zhang D; Fu W; Zhu S; Pan Y; Li R
BMC Genomics; 2024 Apr; 25(1):403. PubMed ID: 38658847
[TBL] [Abstract][Full Text] [Related]
2. The N6-methyladenosine methylation landscape stratifies breast cancer into two subtypes with distinct immunological characteristics.
Chen Y; Hou Y; Li S; Qin W; Zhang J
Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13875. PubMed ID: 38797522
[TBL] [Abstract][Full Text] [Related]
3. Alteration of RNA m6A methylation mediates aberrant RNA binding protein expression and alternative splicing in condyloma acuminatum.
Liu X; Xie B; Wang S; Wu Y; Zhang Y; Ruan L
PeerJ; 2024; 12():e17376. PubMed ID: 38784389
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy.
Wang Y; Sun N; He R; Wang Z; Jin J; Gao T; Qu J
Clin Exp Med; 2024 May; 24(1):92. PubMed ID: 38693353
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
6. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.
Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L
Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449
[TBL] [Abstract][Full Text] [Related]
8. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database.
Jiang Y; Pan Y; Long T; Qi J; Liu J; Zhang M
Front Cardiovasc Med; 2023; 10():1185873. PubMed ID: 37928762
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
Zhou S; Hua R; Quan S
J Ovarian Res; 2023 Apr; 16(1):73. PubMed ID: 37046273
[TBL] [Abstract][Full Text] [Related]
10. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis.
Zhang X; Zhang S; Yan X; Shan Y; Liu L; Zhou J; Kuang Q; Li M; Long H; Lai W
J Cell Mol Med; 2021 Apr; 25(7):3634-3645. PubMed ID: 33724691
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer.
Tian S; Lai J; Yu T; Li Q; Chen Q
Front Oncol; 2020; 10():623634. PubMed ID: 33552994
[TBL] [Abstract][Full Text] [Related]
12. The endoplasmic reticulum stress and the unfolded protein response in kidney disease: Implications for vascular growth factors.
Ricciardi CA; Gnudi L
J Cell Mol Med; 2020 Nov; 24(22):12910-12919. PubMed ID: 33067928
[TBL] [Abstract][Full Text] [Related]
13. KRAS: From undruggable to a druggable Cancer Target.
Uprety D; Adjei AA
Cancer Treat Rev; 2020 Sep; 89():102070. PubMed ID: 32711246
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
